A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.

Also called NCT01945684

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 197 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01945684
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01945684. Randomized; triple masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2014-05 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized, Double Blind, Multi-center, Active Drug Controlled, Phase III Clinical Trial to Compare the Safety and Efficacy of DWP450 Versus Botox® in Treatment of Post Stroke Upper Limb Spasticity
Condition
Spasticity
Condition
Stroke
Intervention (Drug)
Botulinum toxin type A
Lead sponsor
Daewoong Pharmaceutical Co. LTD. (class: industry)

Record details

Record id
cardio:ct-nct01945684
Content hash
399aaae9e4aa31c55b7a2ce431e5c932d652466a1369dad13e14bc23fa484138